CatalystMacro

MATINAS BIOPHARMA GETS 2027 WINDOW TO RESTORE NYSE AMERICAN LISTING COMPLIANCE - SEEKINGALPHA

2027 deadline removes near-term delisting overhang, extending compliance timeline for investors.

What changed

2027 deadline removes near-term delisting overhang, extending compliance timeline for investors.

Why it matters

2027 deadline removes near-term delisting overhang, extending compliance timeline for investors. — impact context not separately stored; see What changed.

Sources

seekingalpha